483
Karl Storz SE & Co. KGFDA 483 - Karl Storz SE & Co. KG - March 12, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Karl Storz SE & Co. KG, a medical device manufacturer in Tuttlingen, Germany, revealed significant deficiencies in their quality system. The firm failed to adequately establish procedures for complaint handling, ensure service reports contained all required information, and control environmental conditions related to electrical energy. These issues indicate systemic problems in maintaining compliance with regulatory requirements.
Open in Dashboard
ID · 3ee24cfc-d62e-44c9-ad4f-3835f53577e6